tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Alnylam Pharma Announces $500M Convertible Notes Offering
PremiumCompany AnnouncementsAlnylam Pharma Announces $500M Convertible Notes Offering
10d ago
Alnylam announces $500M convertible senior notes offering
Premium
The Fly
Alnylam announces $500M convertible senior notes offering
12d ago
Alnylam price target raised to $470 from $450 at BMO Capital
Premium
The Fly
Alnylam price target raised to $470 from $450 at BMO Capital
12d ago
Positive Outlook on Alnylam Pharma’s Hypertension and ATTR-CM Developments
PremiumRatingsPositive Outlook on Alnylam Pharma’s Hypertension and ATTR-CM Developments
18d ago
Cautious Hold Rating on Alnylam Pharma Amid Promising Yet Inconclusive Zilebesiran Trial Results
Premium
Ratings
Cautious Hold Rating on Alnylam Pharma Amid Promising Yet Inconclusive Zilebesiran Trial Results
18d ago
Buy Rating for Alnylam Pharma Driven by Promising Zilebesiran Developments and Strategic Partnership with Roche
Premium
Ratings
Buy Rating for Alnylam Pharma Driven by Promising Zilebesiran Developments and Strategic Partnership with Roche
18d ago
Alnylam’s Phase 2 CAA Study: A Potential Game-Changer in Neurological Treatments
PremiumCompany AnnouncementsAlnylam’s Phase 2 CAA Study: A Potential Game-Changer in Neurological Treatments
22d ago
Alnylam Pharmaceuticals’ ELEVATE Study: A Closer Look at AHP Management
Premium
Company Announcements
Alnylam Pharmaceuticals’ ELEVATE Study: A Closer Look at AHP Management
24d ago
Alnylam’s ALN-APP Study: A Promising Step in Alzheimer’s Treatment
Premium
Company Announcements
Alnylam’s ALN-APP Study: A Promising Step in Alzheimer’s Treatment
24d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100